THE IMPACT OF DEXAMETHASONE ON HEARING-LOSS IN EXPERIMENTAL PNEUMOCOCCAL MENINGITIS

被引:34
|
作者
BHATT, SM
CABELLOS, C
NADOL, JB
HALPIN, C
LAURETANO, A
XU, WZ
TUOMANEN, E
机构
[1] ROCKEFELLER UNIV,MOLEC INFECT DIS LAB,NEW YORK,NY 10021
[2] MASSACHUSETTS EYE & EAR INFIRM,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,DEPT OTOL & LARYNGOL,BOSTON,MA
关键词
MENINGITIS; HEARING LOSS; DEXAMETHASONE; STREPTOCOCCUS PNEUMONIAE;
D O I
10.1097/00006454-199502000-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial meningitis, particularly that resulting from Streptococcus pneumoniae, is a common cause of acquired profound sensorineural deafness in children. The pathogenesis of meningogenic hearing loss has been investigated in an experimental rabbit model. In this study significant deafness was documented within the first 15 hours of infection. Initiation of antibiotic therapy at this time diminished the severity of hearing loss in most animals. The addition of dexamethasone to antibiotic therapy prevented the development of profound deafness. These results suggest this model will be useful in developing antiinflammatory strategies to improve the outcome of bacterial meningitis.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 50 条
  • [41] SENSORINEURAL HEARING-LOSS ASSOCIATED WITH VINCRISTINE TREATMENT
    LUGASSY, G
    SHAPIRA, A
    BLUT, 1990, 61 (05): : 320 - 321
  • [42] Dendritic spine loss deep in the neocortex and dendrite distortion with diffusion disturbances occur early in experimental pneumococcal meningitis
    Baronti, Dario
    Tomov, Nikola
    Hupp, Sabrina
    Mitchell, Timothy J.
    Iliev, Asparouh I.
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [43] Auditory brainstem implantation to rehabilitate profound hearing loss with totally ossified cochleae induced by pneumococcal meningitis
    Grayeli, Alexis Bozorg
    Kalamarides, Michel
    Bouccara, Didier
    Ben Gamra, Loutfa
    Ambert-Dahan, Emmannuelle
    Sterkers, Olivier
    AUDIOLOGY AND NEURO-OTOLOGY, 2007, 12 (01) : 27 - 30
  • [44] Hearing loss during bacterial meningitis
    Richardson, MP
    Reid, A
    Tarlow, MJ
    Rudd, PT
    ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (02) : 134 - 138
  • [45] Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
    Murayama, Yoshiaki
    Ishimine, Tomohiko
    Sasano, Mikio
    Todaka, Takafumi
    Matsumoto, Takashi
    Shimabukuro, Taiga
    Yonaha, Risa
    IDCASES, 2023, 32
  • [46] Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children
    Chapoutot, A. G.
    Dessein, R.
    Guilluy, O.
    Lagree, M.
    Wallet, F.
    Varon, E.
    Martinot, A.
    Dubos, F.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (03) : 607 - 611
  • [47] Folic acid prevented cognitive impairment in experimental pneumococcal meningitis
    Barichello, Tatiana
    Generoso, Jaqueline S.
    Simoes, Lutiana R.
    Steckert, Amanda V.
    Moreira, Ana Paula
    Dominguini, Diogo
    Ferrari, Pamela
    Gubert, Carolina
    Kapczinski, Flavio
    Jornada, Luciano K.
    Danielski, Lucineia G.
    Petronilho, Fabricia
    Budni, Josiane
    Quevedo, Joao
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (05) : 643 - 651
  • [48] Reversible hearing loss following cryptococcal meningitis: case study
    Neo, W. L.
    Durisala, N.
    Ho, E. C.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (07) : 691 - 695
  • [49] Risk Factors for Hearing Loss After Pediatric Meningitis in Japan
    Adachi, Nodoka
    Ito, Ken
    Sakata, Hideaki
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2010, 119 (05) : 294 - 296
  • [50] Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
    Cornelia Blaser
    Matthias Klein
    Denis Grandgirard
    Matthias Wittwer
    Heikki Peltola
    Michael Weigand
    Uwe Koedel
    Stephen L Leib
    BMC Infectious Diseases, 10